TYROScreen SRL
The score of TYROScreen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +8406 % Total assets +2934 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
TYROScreen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 12 Aug 2025
- Year ended 31 Dec 2023filed on 16 Sep 2024
- Year ended 31 Dec 2022filed on 10 Aug 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
TYROScreen's financial analysis
- Solvency58.1%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of TYROScreen
TYROScreen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0672.589.090
- VAT number
- BE0672589090
- Peppol
- Registered · 0208:0672589090 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Mar 2017
- Registered office
- 4653 Herve
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
TYROScreen (SRL) has been based in Herve since 2017, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 29,898 € and equity of 28,209 €; its revenue is not published. Its solvency stands at 58.1%, below the median of its sector (58.2%).
Companies similar to TYROScreen
Companies in the same business, of comparable size and area, outside its group.
- Base LT Research and experimental development on natural sciences and engineering Herbeumont · balance sheet 47,144 €
- Sightera Biosciences Research and experimental development on natural sciences and engineering Heist-op-den-Berg · balance sheet 63,382 €
- Consulting Claudine Demeyere Research and experimental development on natural sciences and engineering Dilbeek · balance sheet 66,460 €
- Dr. Frank Chielens Algemene Geneeskunde Research and experimental development on natural sciences and engineering Ypres · balance sheet 68,508 €
- Plus Breeding Research and experimental development on natural sciences and engineering Lokeren · balance sheet 33,093 €
- DR. Roelandt R. Health Research and experimental development on natural sciences and engineering Affligem · balance sheet 75,195 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- IDA International Research and experimental development on natural sciences and engineering Leuven · balance sheet 101,921 €
Frequently asked questions about TYROScreen
What is the revenue of TYROScreen?
TYROScreen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of TYROScreen?
In Belgium, the VAT number is the company number prefixed with BE: BE0672589090 for TYROScreen, if the company is VAT-registered. Its company number (CBE) is 0672.589.090.
Where is the registered office of TYROScreen?
According to the CBE register, the registered office of TYROScreen is in 4653 Herve.
What is the equity of TYROScreen?
At the close of the 2025 financial year, the equity of TYROScreen amounts to 28,209 €, a solvency of 58.1% of total assets.
Who manages TYROScreen?
The register lists 2 active mandates at TYROScreen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of TYROScreen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →